Clinical Institute of Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia.
Department of Medicinal Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Osijek, Osijek, Croatia.
Biochem Med (Zagreb). 2024 Oct 15;34(3):031001. doi: 10.11613/BM.2024.031001. Epub 2024 Aug 5.
This case report describes interference from heterophilic antibodies in D-dimer assay. The interference was suspected due to discrepancies between D-dimer concentrations in the original sample and diluted samples, as well as inconsistent clinical findings. The patient's medical history, laboratory results, and imaging studies were considered in the investigation. Heterophilic antibodies, likely developed during the SARS-CoV-2 infection, were identified as the probable cause of interference. The interference was confirmed through various methods, including dilution studies, blocking heterophilic antibodies, and comparing results with an alternative D-dimer method. This case highlights the importance of recognizing and addressing interference in D-dimer testing, emphasizing the need for collaboration between clinicians and laboratory specialists.
本病例报告描述了 D-二聚体检测中的异嗜性抗体干扰。由于原始样本和稀释样本中的 D-二聚体浓度存在差异,以及临床发现不一致,怀疑存在干扰。在调查中考虑了患者的病史、实验室结果和影像学研究。鉴定出可能是 SARS-CoV-2 感染期间产生的异嗜性抗体是干扰的可能原因。通过稀释研究、阻断异嗜性抗体以及与替代 D-二聚体方法比较结果等多种方法确认了干扰。本病例突出了识别和解决 D-二聚体检测中干扰的重要性,强调了临床医生和实验室专家之间合作的必要性。